title: Authors' response re: Clarifying costs and benefits of respiratory syncytial virus immunoprophylaxis.
authors.affiliation: Tufts University School of Medicine.
authors.forename: H Cody
authors.initials: HC
authors.lastname: Meissner
authors.forename: David W
authors.initials: DW
authors.lastname: Kimberlin
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000998:Antiviral Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007234:Infant, Premature; D008297:Male; D012135:Respiratory Sounds / Q000187:drug effects*; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*; D012136:Respiratory Syncytial Viruses / Q000187:drug effects*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents